M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Factors influencing concordance between clinical and ultrasound findings in rheumatoid arthritis.
Marion Le Boedec,Sandrine Jousse-Joulin,Jean-François Ferlet,Thierry Marhadour,Gérard Chalès,Laurent Grange,Cécile Hacquard-Bouder,Damien Loeuille,Jérémie Sellam,Jean-David Albert,Jacques Bentin,Isabelle Chary-Valckenaere,Maria Antonietta D'Agostino,Fabien Etchepare,Philippe Gaudin,Christophe Hudry,Maxime Dougados,Alain Saraux +17 more
TL;DR: In this paper, the authors identify factors associated with joint concordance between clinical joint examination (CJE) and power Doppler US (PDUS) in rheumatoid arthritis.
Journal Article
Glucocorticoid sparing effect of tumour necrosis factor alpha inhibitors in rheumatoid arthritis in real life practice.
TL;DR: A significant GC sparing-effect of anti-TNF-alpha in RA patients in real life practice was observed for oral, parenteral and intra-articular administration, as early as the first 3 months of treatment.
Journal ArticleDOI
Ability of oblique foot radiographs to detect erosions in early arthritis: results in the ESPOIR cohort.
Valérie Devauchelle-Pensec,Thierry Josseaume,Isabelle Samjee,Maxime Dougados,Bernard Combe,Alain Saraux +5 more
TL;DR: The usefulness of using oblique foot radiographs in addition to posteroanterior radiographs of the hands and feet for detecting erosions in patients with recent-onset arthritis was assessed.
Journal ArticleDOI
Association of a polymorphism in the collagen I α1 gene with osteoporosis in French women
Journal ArticleDOI
Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
Maxime Dougados,Emily Wood,Bernard Combe,Thierry Schaeverbeke,Corinne Miceli-Richard,Francis Berenbaum,Nandan Koppiker,Arnaud Dubanchet,Isabelle Logeart +8 more
TL;DR: In patients with axSpA, etanercept was associated with clinically relevant NSAID-sparing effects in addition to significant improvements in conventional clinical outcomes, and this study was the first of its kind to assess the effects of the anti-tumor necrosis factor agent on NSAID intake and conventionalclinical outcomes.